Concepedia

J. Brad Shotwell

JB

Statistics

Publications

32

Citations

1.6K

H-Index

26

Active since

1999

Affiliations

GlaxoSmithKline (United States)(Current)

Research Triangle Park Foundation

AbbVie (United States)

Yale University

University of Michigan

J. Brad Shotwell is an author at GlaxoSmithKline (United States) specializing in drug discovery, medicinal chemistry, and pharmacy.

Publications per year

1999–2024

32

Publications

32

Integrated Metabolic and Epigenomic Reprograming by H3K27M Mutations in Diffuse Intrinsic Pontine Gliomas

Chan Chung, Stefan R. Sweha, Drew Pratt et al. · Cancer Cell · 2020 · 221 citations · Full text

Medicine, Genetics, Oncology +12

GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers

Peter Sabbatini, Susan Korenchuk, Jason L. Rowand et al. · Molecular Cancer Therapeutics · 2009 · 98 citations · Full text

Medicine, Oncology, Pharmacology +13

The Role of Phosphodiesterase 12 (PDE12) as a Negative Regulator of the Innate Immune Response and the Discovery of Antiviral Inhibitors

Edgar R. Wood, Randy K. Bledsoe, Jing Chai et al. · Journal of Biological Chemistry · 2015 · 80 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Fragment-based discovery of DNA gyrase inhibitors targeting the ATPase subunit of GyrB

Michael F. Mesleh, Jason B. Cross, Jing Zhang et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 73 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12

Structure and Energetics of the Samarium Diiodide−HMPA Complex in Tetrahydrofuran

J. Brad Shotwell, Jennifer M. Sealy, Robert A. Flowers · The Journal of Organic Chemistry · 1999 · 71 citations

Natural Sciences, Chemistry, Analytical Chemistry +13

1–5 of 32